Thiola EC 100 MG tablet 300S
Ended Awarded Last action
- Contract number
- SPE2DR26FMEA5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,425
Award facts
- Contract value 100% obligated
- $12,425.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,425.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Thiola EC 100 mg tablets (300 count). This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and will be performed at the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was recently established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, valued at $499.999 billion and running through December 31, 2036, positions DMS Pharmaceutical Group as a critical pharmaceutical supplier supporting Department of Defense military healthcare facilities worldwide. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy authorizing DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to meet recurring medical supply needs across the military health system.
Quick answers
Who was awarded contract SPE2DR26FMEA5?
SPE2DR26FMEA5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FMEA5 worth?
The government has obligated $12,425 on SPE2DR26FMEA5.
Is contract SPE2DR26FMEA5 an order under another contract?
Yes. SPE2DR26FMEA5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEA5 competed?
The extent of competition for SPE2DR26FMEA5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award